Association of SLCO1B1 gene variants with angiotensin-converting enzyme inhibitor-induced cough in a Pakistani hypertensive cohort
- PMID: 39295941
- PMCID: PMC11408173
- DOI: 10.3389/fphar.2024.1441251
Association of SLCO1B1 gene variants with angiotensin-converting enzyme inhibitor-induced cough in a Pakistani hypertensive cohort
Abstract
Background: Angiotensin-converting enzyme inhibitors (ACEIs) are prescribed for individuals with high cardiovascular (CV) risk; however, persistent cough limits the use of ACEIs in a large number of patients. The current study aimed to identify the genetic variants in the SLCO1B1 gene that might be associated with ACEI-related cough in a Pakistani hypertensive population.
Methods: A prospective cohort study was conducted at a tertiary care hospital in Pakistan. A total of 74 patients who had been treated with ACEIs were recruited through a convenient sampling method. The study was approved by the Institutional Review Board & Ethics Committee of the Shifa International Hospital, Islamabad. Patients provided 2 ml of blood for sequencing after signing informed consent. Partial gene sequencing of SLCO1B1 was carried out to find single nucleotide polymorphisms (SNPs) and haplotypes.
Results: It was found, through a structured questionnaire, that thirty-eight (38) patients experienced cough within 2 weeks of ACEI administration and were considered as a case group (cough), and thirty-six (36) patients were considered as a control group (no cough). The incidence of cough was 51%. We found six different SNPs and 9 haplotypes in the partial gene sequences of SLCO1B1. Haplotype H4 was associated significantly with cough after adjusting for sex and smoking status. Other SNPs and haplotypes were not significantly associated with ACE-Is-induced cough.
Conclusion: These findings emphasize the significance of SLCO1B1 genetic variants, specifically H4, as a potential predictor of ACEI-induced cough. It could be included in clinical practice as a possible risk factor for ACEI-induced cough once confirmed in larger clinical trials with bigger sample sizes. The replication of these findings in larger and more diverse populations is likely to contribute to the therapeutic use of ACEIs by predicting ACEI-induced cough.
Keywords: ACE inhibitors; SLCO1B1; adverse effects; dry cough; single nucleotide polymorphisms.
Copyright © 2024 Sheikh, Munawar, Nawaz, Khan, Rafique, Jahan and Ahmed.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery.Yonsei Med J. 2022 Apr;63(4):342-348. doi: 10.3349/ymj.2022.63.4.342. Yonsei Med J. 2022. PMID: 35352885 Free PMC article.
-
Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study.Front Pharmacol. 2023 Sep 20;14:1267924. doi: 10.3389/fphar.2023.1267924. eCollection 2023. Front Pharmacol. 2023. PMID: 37799968 Free PMC article.
-
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.Sci Rep. 2015 Nov 26;5:17253. doi: 10.1038/srep17253. Sci Rep. 2015. PMID: 26607661 Free PMC article.
-
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?Eur J Intern Med. 2023 Apr;110:10-15. doi: 10.1016/j.ejim.2023.01.005. Epub 2023 Jan 8. Eur J Intern Med. 2023. PMID: 36628825 Review.
-
ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction.Indian Heart J. 2020 Sep-Oct;72(5):345-350. doi: 10.1016/j.ihj.2020.08.007. Epub 2020 Aug 10. Indian Heart J. 2020. PMID: 33189192 Free PMC article. Review.
References
-
- Ahmed N., Abdul Khaliq M., Shah S. H., Anwar W. (2008). Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad. J. Ayub Med. Coll. Abbottabad No. 20 (2), 66–69. - PubMed
-
- Alam F., Batool G., Noureen S., Khan M. S., Zaman I., Jamil ur Rehman, et al. (2024). The prescribing trends of ace-inhibitors after myocardial infarction in tertiary care hospitals of hazara region. Int. J. Pharm. & Integr. Health Sci. 5 (1). 10.56536/ijpihs.v5i1.120 - DOI
-
- Ali F., Shahid F., Shahid T. (2023). Aqueous extract of malus domestica inhibits human platelet aggregation induced by multiple agonists. Phytopharm. Commun. 3 (01), 27–37. 10.55627/ppc.003.01.0289 - DOI
-
- Carr D. F., O'meara H., Jorgensen A. L., Campbell J., Hobbs M., McCann G., et al. (2013). SLCO1B1 genetic variant associated with statin-induced myopathy: a proof of concept study using the clinical practice research datalink. Clin. Pharmacol. & Ther. 94 (6), 695–701. 10.1038/clpt.2013.161 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous